Inventor · disambiguated record
Husseini K. Manji
Also filed as: MANJI HUSSEINI · MANJI HUSSEINI K
7 granted patents·5 pending applications·81 citations·filing 2002–2023
84Inventor score
Files withICAHN SCHOOL MED MOUNT SINAI5JANSSEN PHARMACEUTICA NV2US HEALTH2CHARNEY DENNIS S1US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH1
Top patents by PatentIndex Score
12 records- 0193US9592207B2Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Mar 14, 2017·14 cites·15 claims
- 0293US8785500B2Intranasal administration of ketamine to treat depressionCHARNEY DENNIS S·Filed 2007·Granted Jul 22, 2014·55 cites·18 claims
- 0389US9539220B2Methods for treating suicidal ideationICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Granted Jan 10, 2017·5 cites·9 claims
- 0476US7906283B2Methods to identify patients at risk of developing adverse events during treatment with antidepressant medicationUS HEALTH·Filed 2007·Granted Mar 15, 2011·2 cites·4 claims
- 0569US2020253894A1Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2020·Application pending·0 cites
- 0665US2017151191A1Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Application pending·0 cites
- 0765US2017181966A1Intranasal administration of ketamine to treat depressionICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Application pending·0 cites
- 0863US7795033B2Methods to predict the outcome of treatment with antidepressant medicationUS HEALTH·Filed 2008·Granted Sep 14, 2010·5 cites·25 claims
- 0960US12073742B2System and method for assessing cognitive and mood states of a real world user as a function of virtual world activityJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 27, 2024·0 cites·19 claims
- 1050US11615713B2System and method for assessing cognitive and mood states of a real world user as a function of virtual world activityJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 28, 2023·0 cites·19 claims
- 1146US2011118133A1Methods to identify patients at risk of developing adverse events during treatment with antidepressant medicationUS OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH·Filed 2011·Application pending·0 cites
- 1244US2003103945A1Methods and compositions for stimulating axon regeneration and preventing neuronal cell degenerationFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →